Several drug stocks are at risk as the Federal Trade Commission is going after pharmaceutical companies that it alleges are ...

When Amylyx Pharmaceuticals found out its ALS drug Relyvrio didn't work, the company took the unusual step of voluntarily ...

After pressure from activist investors, BioMarin Pharmaceutical Inc. is slashing jobs and reshuffling its drug portfolio.

Substituted urine samples increased by sixfold, while marijuana positive screens jumped in finance and real estate, according ...

Sometimes a drug shortage is a nuisance. Other times, the repercussions could be more serious, as is the case with ...

Parallel Bio, a biotech company using the immune system to cure disease, today announced the release of its Clinical Trial in a Dish for studying the efficacy and safety of new immunotherapies using ...

Major drug companies have been snatching up biotech companies that developing antibody-drug conjugates (ADCs) targeting a ...

The percentage of the general workforce who substituted other people’s urine in office drug tests surged 600% to a new high ...

NewVale Capital now has nearly $200 million total under management and plans to invest between $10 million and $50 million in ...

This analysis did not drill down to the level of individual patents to assess their legitimacy, Kesselheim stressed. However, ...

Cancer drug trials are structured to promote high doses, which then become routine patient care. In the face of evidence that ...